Fontanez, Nelson
Tufts University · City University of New York · Regeneron (United States) · University of Washington · Sanofi (France) · Sanofi (United States) · Columbia University
2 papers on CoChat
Most cited papers
- Verified
Effects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans
Reyes-Soffer, G., Pavlyha, M., Ngai, C., Thomas, T., Holleran, S., Ramakrishnan, R., Karmally, W., Nandakumar, R., Fontanez, N., Obunike, J., et al. (2017) · Circulation
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 240
- Verified
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
Nagashima, K., Lopez, C., Donovan, D., Ngai, C., Fontanez, N., Bensadoun, A., Fruchart-Najib, J., Holleran, S., Cohn, J. S., Ramakrishnan, R., et al. (2005) · Journal of Clinical Investigation
Lipid metabolism and disordersPeroxisome Proliferator-Activated Receptors
Cited by 201
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free